Library / Laws / 118th Congress / House Bills / H.R. 4053
H.R. 4053
To provide for the review of the scheduling under the Controlled Substances Act of buprenorphine-naloxone combination products, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-06-13 | 1.7K | ⠃⠗⠋ |